IOP Clinical Trials in Los Angeles, California
22 recruitingLos Angeles, California
Showing 1–20 of 22 trials
Recruiting
Phase 1
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Lupus Nephritis+2 more
Fate Therapeutics244 enrolled18 locationsNCT06308978
Recruiting
Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis
Boehringer Ingelheim1,700 enrolled371 locationsNCT06238622
Recruiting
Phase 2
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.340 enrolled52 locationsNCT06951217
Recruiting
Phase 2
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Cerebral Amyloid Angiopathy
Alnylam Pharmaceuticals200 enrolled57 locationsNCT06393712
Recruiting
Phase 2
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Parkinson DiseaseParkinsonParkinson Disease, Idiopathic+2 more
Neuron23 Inc.150 enrolled70 locationsNCT06680830
Recruiting
Phase 3
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
CSL Behring200 enrolled19 locationsNCT07094087
Recruiting
Phase 2
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Mediar Therapeutics164 enrolled65 locationsNCT06967805
Recruiting
Phase 2
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Calluna Pharma AS150 enrolled54 locationsNCT06736990
Recruiting
Phase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Idiopathic Short Stature
BioMarin Pharmaceutical100 enrolled47 locationsNCT06382155
Recruiting
Phase 2
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis (IPF)
Vicore Pharma AB360 enrolled117 locationsNCT06588686
Recruiting
Advanced SPinal Innovations With Robotics and Enabling Technology Registry
SpondylolisthesisAdolescent Idiopathic ScoliosisCongenital Scoliosis+3 more
Boston Children's Hospital700 enrolled10 locationsNCT05071144
Recruiting
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Duke University3,000 enrolled41 locationsNCT01915511
Recruiting
Phase 2
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
Idiopathic Hypersomnia
Alkermes, Inc.96 enrolled48 locationsNCT06843590
Recruiting
Not Applicable
Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
PainAnxietyBreast Biopsy
Jonsson Comprehensive Cancer Center600 enrolled1 locationNCT07310004
Recruiting
Phase 1Phase 2
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
Parkinson's DiseaseIdiopathic Parkinson´s Disease
Kenai Therapeutics12 enrolled3 locationsNCT07106021
Recruiting
A Study to Assess Growth in Children With Idiopathic Short Stature
Idiopathic Short Stature
BioMarin Pharmaceutical300 enrolled40 locationsNCT06309979
Recruiting
Phase 2
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF)
InSilico Medicine Hong Kong Limited40 enrolled12 locationsNCT05975983
Recruiting
Phase 2
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Cedars-Sinai Medical Center60 enrolled1 locationNCT06567717
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Cardiac ArrestCardiopulmonary Arrest
Children's Hospital of Philadelphia7,000 enrolled61 locationsNCT02708134
Recruiting
Early Phase 1
FAPI PET for Lung Fibrosis
PneumoconiosisRadiation PneumonitisInterstitial Lung Disease+4 more
University of California, Los Angeles30 enrolled1 locationNCT05365802